Corporate Office HQ

Biotechnology

Physicians Toxicology Laboratory Corporate Office

Physicians Toxicology Laboratory was founded in 2011 by CEO and President  Matthew Ryan Lund. Originally based in Naples, Florida, the business now has offices in Tampa, Florida, as well as Kalamazoo, Michigan. The company specializes in providing routine drug testing for pre-employment or randomized testing for the presence of illegal drug use or noncompliance of prescription drugs, which allows doctors to monitor their patients’ drug use.

Physicians Toxicology Laboratory is #59 on the 2015 Inc. 5000 list of Fastest-Growing Private Companies in the U.S., with a three year growth rate of 4,415%. The company has 37 employees with 24 of those jobs added in the past 3 years and $9 million in revenue in 2014.

The company is listed as #7 on the Inc. list of Top Health Companies, #7 in Top Tampa Companies, and #2 in Top Florida Companies.

Physicians Toxicology Laboratory

Physicians Toxicology Laboratory was founded in 2011 by CEO and President  Matthew Ryan Lund. Originally based in Naples, Florida, the business now has offices in Tampa, Florida, as well as Kalamazoo, Michigan. The company specializes in providing routine drug testing for pre-employment or randomized testing for the presence of illegal drug use or noncompliance of prescription drugs, which allows doctors to monitor their patients’ drug use.

Physicians Toxicology Laboratory is #59 on the 2015 Inc. 5000 list of Fastest-Growing Private Companies in the U.S., with a three year growth rate of 4,415%. The company has 37 employees with 24 of those jobs added in the past 3 years and $9 million in revenue in 2014.

The company is listed as #7 on the Inc. list of Top Health Companies, #7 in Top Tampa Companies, and #2 in Top Florida Companies.

History

Covance Corporate Office

Covance was founded in 1968 as Environmental Sciences Corporation in Seattle, Washington.

In 1972 the company bought Hazleton Laboratories, a laboratory that conducted toxicology testing, and took on that name. By 1982, Hazleton had become the largest biological testing company in the U.S.

Covance was purchased by Labcorp in 2014 in a $6.1 billion deal.

Today the company provides testing services, including toxicology studies and biostatistical analysis for pharmaceutical and biotech companies. Other clients include companies in the food, agrochemical, and chemical industries. The company also provides testing services which include designing and realizing human clinical trials.

Covance

Covance was founded in 1968 as Environmental Sciences Corporation in Seattle, Washington.

In 1972 the company bought Hazleton Laboratories, a laboratory that conducted toxicology testing, and took on that name. By 1982, Hazleton had become the largest biological testing company in the U.S.

Covance was purchased by Labcorp in 2014 in a $6.1 billion deal.

History

Today the company provides testing services, including toxicology studies and biostatistical analysis for pharmaceutical and biotech companies. Other clients include companies in the food, agrochemical, and chemical industries. The company also provides testing services which include designing and realizing human clinical trials.

Beckman Coulter Corporate Office

Beckman Coulter is a manufacturer of biomedical laboratory instruments.

The company was founded in 1935 by Arnold O. Beckman as National Technical Laboratories to make and sell a PH meter that he had invented.

In 1940 Beckman changed the company’s name to Arnold O. Beckman, Inc. and diversified to oxygen analyzers, potentiometers, and spectrophotometers.

In the 1950’s Beckman established his first laboratory and began marketing semiconductor transistor technology.

Today Beckman Coulter develops, manufactures, and markets products for biomedical testing. Over 275,000 Beckman Coulter systems operate in Diagnostic and Life Sciences laboratories throughout the world. Clients include hospitals, laboratories, and scientists.

In 2011 Beckman Coulterwas was acquired by the Danaher Corporation.

Beckman Coulter

Beckman Coulter is a manufacturer of biomedical laboratory instruments.

The company was founded in 1935 by Arnold O. Beckman as National Technical Laboratories to make and sell a PH meter that he had invented.

In 1940 Beckman changed the company’s name to Arnold O. Beckman, Inc. and diversified to oxygen analyzers, potentiometers, and spectrophotometers.

History

In the 1950’s Beckman established his first laboratory and began marketing semiconductor transistor technology.

Today Beckman Coulter develops, manufactures, and markets products for biomedical testing. Over 275,000 Beckman Coulter systems operate in Diagnostic and Life Sciences laboratories throughout the world. Clients include hospitals, laboratories, and scientists.

In 2011 Beckman Coulterwas was acquired by the Danaher Corporation.

Biogen Idec Corporate Office

Biogen Idec is a biotechnology company based in Cambridge, Massachusetts.

The company was founded by prominent biologists Sir Kenneth Murray, Charles Weissmann, and Phillip Sharp in 1978 in Geneva.

Biogen focuses on developing treatments primarily for immunology and neurology. Popular drugs include Avonex, which treats relapsing MS, Tysabrim, a treatment for MS and Crohn’s disease, Rituxan, which treats non-Hodkin’s lymphoma and rheumatoid arthritis, and Fumaden, a treatment for psoriasis.

The company has customers in over 90 countries worldwide.

In March 2020, Biogen employees unwittingly spread the COVID-19 virus from it’s home office in Massachusetts to Indiana, Tennessee, and North Carolina, after a company leadership meeting. 

Company shares also rose in March as investors looked for “safe” places to park their money and ride out the pandemic. 

Biogen Idec trades publicly on the NASDAQ under the ticker symbol BIIB, is a member of the S&P 500, is #375 in the Fortune 500, has 7,300 employees, and had $12.274 billion in revenue in 2017.

Biogen Idec

Biogen Idec is a biotechnology company based in Cambridge, Massachusetts.

The company was founded by prominent biologists Sir Kenneth Murray, Charles Weissmann, and Phillip Sharp in 1978 in Geneva.

History

Biogen focuses on developing treatments primarily for immunology and neurology. Popular drugs include Avonex, which treats relapsing MS, Tysabrim, a treatment for MS and Crohn’s disease, Rituxan, which treats non-Hodkin’s lymphoma and rheumatoid arthritis, and Fumaden, a treatment for psoriasis.

The company has customers in over 90 countries worldwide.

In March 2020, Biogen employees unwittingly spread the COVID-19 virus from it’s home office in Massachusetts to Indiana, Tennessee, and North Carolina, after a company leadership meeting. 

Company shares also rose in March as investors looked for “safe” places to park their money and ride out the pandemic. 

Biogen Idec trades publicly on the NASDAQ under the ticker symbol BIIB, is a member of the S&P 500, is #375 in the Fortune 500, has 7,300 employees, and had $12.274 billion in revenue in 2017.

Baxter International Corporate Office

Baxter International is a healthcare company that focuses on products to treat hemophilia, kidney disease, immune disorders, and other chronic and acute medical conditions.

The company was founded by David Baxter in 1931 as a manufacturer and distributor of intravenous therapy.

Just four years later in 1935 Ralph Falk bought out David Baxter and added a research and development branch to the company.

In 1939 Baxter International developed a vacuum-type collection container that extended the shelf life of blood from hours to weeks.

In 1954 the company expanded internationally for the first time with an office in Belgium.

Today Baxter International makes a variety of medicines and medical products, operating in two divisions: Medical Products and Bio Science.

Baxter International trades publicly on the New York Stock Exchange under the symbol BAX, is a member of the S&P 500, is #185 in the Fortune 500, has 61,000 employees, and had $15.76 billion in revenue in 2013.

 

Baxter International

Baxter International is a healthcare company that focuses on products to treat hemophilia, kidney disease, immune disorders, and other chronic and acute medical conditions.

The company was founded by David Baxter in 1931 as a manufacturer and distributor of intravenous therapy.

Just four years later in 1935 Ralph Falk bought out David Baxter and added a research and development branch to the company.

History

In 1939 Baxter International developed a vacuum-type collection container that extended the shelf life of blood from hours to weeks.

In 1954 the company expanded internationally for the first time with an office in Belgium.

Today Baxter International makes a variety of medicines and medical products, operating in two divisions: Medical Products and Bio Science.

Baxter International trades publicly on the New York Stock Exchange under the symbol BAX, is a member of the S&P 500, is #185 in the Fortune 500, has 61,000 employees, and had $15.76 billion in revenue in 2013.